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Abstract
Immunohistochemistry (IHC) is a process of selectively imaging antigens in 
cells or tissue sections by exploiting antibody specificity. This technique is widely 
used in diagnostic pathology and research experiments for tracking specific 
molecular markers characteristic of a particular cell type or cellular events such as 
cancerous cell development, cell proliferation, or apoptosis. Visualizing the target 
antigen following an antibody-antigen interaction is accomplished by different 
detection systems. In the simplest instance, primary antibody directly conjugated 
to an enzyme is responsible for both specifically binding to the antigen and catalyz-
ing a color-producing reaction. Alternatively, complex detection systems could be 
designed to profoundly improve minimal detection level of the antigen. During the 
past years, there has been a considerable improvement in designing and introduc-
tion of new and highly sensitive detection systems. The choice of an IHC detection 
system is a compromise of a variety of variables including desired sensitivity, cost, 
and the time needed for an IHC staining to be performed. This chapter covers the 
immunohistochemistry detection systems with emphasis on their principle, history, 
advantages, and limitations and delineates factors needed to be considered for 
choosing an appropriate detection system for IHC applications.
Keywords: immunohistochemistry, antibody, detection systems, sensitivity, 
background
1. Introduction
Immunohistochemistry (IHC) represents a way to build a picture of particular 
distribution and localization of molecular markers within cells and in the proper 
tissue context and is a powerful tool that provides important diagnostic, prognos-
tic, and predictive information supplemental to the morphological assessment of 
the tissues. Although less sensitive quantitatively than such immunoassays as west-
ern blotting or ELISA, IHC enables observation of molecular signature in the con-
text of intact tissue. In its very simplified method, IHC visualizes target antigens 
by using target-specific antibodies tagged with appropriate labels. However, lack 
of need for labeling of molecular marker-specific primary antibodies and higher 
sensitivity made indirect staining methods as the preferred staining method. The 
need for more sensitive detection systems in case of minimally expressed markers 
was a provocative factor that eventually led to the emergence of next genera-
tions of IHC detection methods with the hope to amplify staining signal. IHC 
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methods based on avidin-biotin interaction and polymer- and tyramide-based 
signal amplification are among IHC signal amplification methods that have greatly 
enhanced the sensitivity of IHC staining. However, when more sensitive methods 
are used, background signal tends to increase along with the target signal and so 
highly sensitive detection systems are not always desirable. Therefore, the optimal 
IHC method is planned as a compromise between sensitivity that allows proper 
and reliable visualization of a given molecular marker and at the same time avoid-
ing background signals that impair staining index and specificity of the staining 
method. In an optimal IHC detection system, tissue type, level of expression of 
the marker of interest, localization of the marker, and cost are among important 
factors that should be taken into consideration. As a general rule of thumb, there is 
no a bona fide IHC detection method that is universally accepted. Although it does 
not rely on chemical reactions that take place in IHC, immunofluorescence (IF) 
staining follows almost the same rules as with IHC and so concerns on detection 
systems that are also applicable to IF staining methods. In this chapter, we will 
focus on detection methods in immunohistochemistry and immunofluorescence 
stainings and highlight in detail potential application, advantages, and disadvan-
tages of each method.
2. Direct method
Direct detection methods are known as a one-step process applying a primary 
antibody, which is directly labeled with reporter molecules, such as biotin, colloidal 
gold, fluorochromes, or enzymes [1, 2]. The conjugated antibody makes a direct 
contact with cognate antigen in histological or cytological preparations (Figure 1). 
Direct detection methods are widely used for detecting highly expressed antigens. 
Furthermore, when the use of the secondary antibodies causes nonspecific and 
unwanted reactions, owing to the histological nature of the tissue and/or host spe-
cies of the primary antibody, direct detection could be the technique of choice. For 
instance, in case of mouse lymph node immunostaining, labeled primary mouse 
monoclonal antibodies are preferred because antimouse secondary antibodies are not 
only bound to mouse primary antibodies bound to the tissue antigens of interest but 
will also react with endogenous immunoglobulins vastly found in lymph nodes. This 
would lead to a strong nonspecific staining. Hence, direct detection methods using 
mouse primary antibodies conjugated to a fluorophore or enzyme would be a better 
option [3]. If this approach is not practically feasible, for example, due to the low 
expression level of the target antigen or technical problems in primary antibody label-
ing, indirect methods using primary antibodies from species other than that of target 
tissue would be desirable.
One of the advantages of direct detection is that the incubation step with a 
secondary reagent is eliminated. Hence, this method is time saving and easy to 
Figure 1. 
Direct immunostaining method.
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perform. In addition, due to the wide range of fluorochromes that are commercially 
available, direct detection is vastly used in multicolor experimental designs [4, 5].
It is important to note that insufficient sensitivity to detect most of the antigens 
found in routinely processed tissues is one of the drawbacks of using direct detec-
tion method. Furthermore, each primary antibody needs to be individually conju-
gated with fluorophores or enzymes, which increases considerably the cost of the 
whole process. Another concern with direct staining methods is the possibility of 
functional impairment of the antibody affinity if the process of antibody labeling is 
nonoptimal. This is especially case for monoclonal antibodies in which all antibody 
molecules in a given preparation have almost the same affinity and so are most 
likely to be affected all together by improper labeling. This issue is less problematic 
for polyclonal antibodies in which antibodies with diverse physicochemical proper-
ties are produced against an antigen [5–7].
Needless to say, direct detection methods are the method of choice in such 
high-sensitive protein detection systems as flow cytometry. Although this system 
is the simplest and the most convenient method for detection of a given marker 
expression, it is not routinely employed in clinical and research applications due to 
the limitations mentioned above.
3. Indirect method
The need for more sensitive detection systems for antigens with low expression 
pattern was a provoking factor that prompted Coons et al. in 1941 to develop two-
step detection methods [8]. This system employs an unlabeled primary antibody 
as the first layer and the secondary antibody, which is raised against the primary 
antibody and is labeled with different fluorophores or enzymes (Figure 2)  
[6, 9–11]. In indirect methods, primary antibodies retain full avidity because 
they remain unlabeled. Indeed, higher number of labels per molecule of primary 
antibody is achieved in indirect compared to direct detection methods. The later 
stems from the fact that at least two labeled secondary antibodies can bind to each 
primary antibody molecule. These factors result in increased reaction intensity 
and the higher sensitivity in indirect staining methods. Accordingly, indirect 
methods are able to detect fewer number of antigens with less primary antibody. 
Moreover, indirect methods are more practical than direct methods since the 
same secondary antibody can be applied for detection of different sets of primary 
antibodies if they have been raised in the same species [12]. Another benefit 
of indirect method in IF stainings is possibility to select secondary antibodies 
with fluorophores of different colors. For example, if the tissue shows strong 
endogenous red autofluorescence, the secondary antibody labeled with green 
Figure 2. 
Indirect immunostaining method.
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fluorophore could be a right choice [3]. Previously mentioned advantages of indi-
rect detection systems eventually led to its widespread applications in research 
and clinical settings.
Despite advantages mentioned above, indirect immunostaining methods suffer 
from some shortcomings. First, additional controls and blocking steps are inevi-
table when using secondary antibodies. Indeed, there is possibility of nonspecific 
staining that happens when the secondary antibody interacts with unwanted tissue 
targets. If nonspecific staining is noticed, blocking reagents have to be used to treat 
the tissue sections that could be time-consuming and cause additional costs to 
IHC experiment [6, 13]. The blocking agent should contain nonimmune antibody 
fraction from the same species in which secondary antibody has been produced. 
This results in competitive blocking of the nonspecific binding sites for secondary 
antibody in the target tissue by the unlabeled antibodies from the same species. 
The addition of further layers beyond their use in the two-step indirect method for 
increasing the sensitivity of detection can be problematic as addition of every new 
species of antibody considerably increases the risk of nonspecific interactions and 
background staining [14]. Desire for more sensitive detection systems triggered 
researchers to develop next-generation detection systems, especially for those 
antigenic markers, which are not expressed in physiological condition, and any level 
of their upregulation would be interpreted as a pathological condition.
4. Bridge methods
Early conjugation protocols were not efficient and did not label all antibodies 
leaving a fraction of antibodies unlabeled. These unlabeled antibodies were able 
to compete with labeled antibodies for binding to the cognate antigen and reduced 
the efficiency of detection. To overcome this problem, new approaches were 
invented that eliminated the need for chemical conjugation of antibodies. In these 
approaches, antigen specificity of antibodies is employed to couple antibodies to the 
enzymes. Taking advantage of antigen specificity of antibodies, antiperoxidase or 
antialkaline phosphatase antibodies are easily coupled with peroxidase or alkaline 
phosphatase after incubation with these enzymes without need for any chemi-
cal modifications of the antibody. These preformed soluble enzyme-antienzyme 
immune complexes are then used as the third layer reporter antibody for detection 
of the antigen-bound primary antibody in tissue section. Taking advantage of the 
bivalent properties of IgG binding, a second-step antibody with binding specificity 
to primary antibody and tertiary antienzyme antibody complexed with the enzyme 
bridges two layers (Figure 3a). The bridge antibody is usually used in excess, so that 
one of its two identical binding sites interacts with enzyme-coupled tertiary anti-
body, while the other site interacts with primary antibody. The tertiary antienzyme 
antibody has the same animal species of origin as the primary antibody. The bridge 
methods are collectively called as soluble enzyme-antienzyme methods [5, 8, 15–17].
The classical immunoenzyme bridge method [18] was rapidly replaced with 
an improved version in which peroxidase-antiperoxidase complex (PAP, MW: 
400–430 KDa) contained three peroxidase molecules and two antiperoxidase anti-
bodies (Figure 3b) [15]. In this system, antibodies against alkaline phosphatase can 
also be employed to form alkaline phosphatase-antialkaline phosphatase complexes 
(APAAP, MW: approximately 560 KDa) [17]. In contrast to PAP complexes, APAAP 
complexes include two molecules of alkaline phosphatase and only one antibody. The 
APAAP method is usually used as an alternative to PAP technique when high levels of 
endogenous peroxidase in such tissues as bone marrow aspirate specimens, spleen and 
peripheral blood, interfere with the staining or when double labeling approaches are 
desired [19].
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Soluble enzyme-antienzyme methods offer several advantages over direct 
and indirect detection methods. The drawback of chemical conjugation process, 
which could potentially lead to impairment of antibody activity, is entirely avoided 
in enzyme-antienzyme methods. Due to a greater number of enzyme molecules 
localized per antigenic site, enzyme-antienzyme process shows the higher sensi-
tivity compared to previously described methods. It is reported that PAP method 
exhibits nearly 100- to 1000-fold higher sensitivity than two-step indirect method 
[7]. Although multilayering of detection antibodies could potentially increase the 
risk for nonspecific interaction with the tissue antigens, PAP and APAAP methods 
that offer triple level detection are among the exceptions. These methods are suit-
able for cell and cryosection IHC [14].
In comparison to two-step indirect methods, PAP and APAAP are more time-
consuming. Indeed, these methods may not have sensitivity enough required for 
use in formalin-fixed paraffin-embedded (FFPE) preparations, especially when 
used in combination with monoclonal antibodies [14]. Although PAP and APAAP 
methods have been known as the highly sensitive, reliable, and popular techniques 
in pathology laboratories for a long time, they have gradually been replaced by more 
improved methods such as streptavidin-biotin- and polymer-based systems.
5. Biotin-avidin/streptavidin-based methods
5.1 Labeled avidin/streptavidin-biotin (LAB/LSAB)
Labeled avidin/streptavidin-biotin (LAB/LSAB) are among very sensitive IHC 
detection methods, which take advantage of high-affinity binding of avidin/strep-
tavidin to a water-soluble vitamin, biotin (vitamin H or B7) [5, 20–22]. The affinity 
constant of avidin binding to biotin (1015 M−1) is nearly 103–106 times more than the 
binding affinity of antibody-antigen interaction [22].
Figure 3. 
Two- (a) and three-step (b) bridge immunostaining methods.
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The potential of avidin-biotin system to be used in immunoassays was inspired 
for the first time from a study in 1972 in which it has been shown that avidin could 
inactivate the biotinylated bacteriophages [23]. Avidin-biotin-based system was 
used for the first time in an immunological experiment in 1976 when an erythrocyte 
surface antigen was localized by using biotin-labeled antibody and ferritin-avidin 
conjugate [24]. In 1979, Guesdon et al. showed that avidin-biotin complex could be 
effectively used for immunoassays. Using avidin-biotin system, they suggested dif-
ferent related methods for enhancing the specificity and sensitivity of solid-phase 
immunoassays. They also used avidin-biotin-based immunohistochemistry for 
localization of intracellular immunoglobulins [25].
The principle of labeled avidin-biotin (LAB) technique is based on sequential 
interaction of biotin-labeled antibody with tissue antigen and enzyme-labeled 
avidin with biotinylated primary antibody (Figure 4a). In the bridged avidin-biotin 
(BRAB) technique, however, avidin bridges biotin-labeled primary antibody and 
biotin-labeled enzyme (Figure 4b). BRAB is particularly suitable in cases where 
intracellular penetration and/or sensitivity of the staining reaction are the major 
concerns. An indirect approach of BRAB technique (IBRAB) can also be applied for 
identification of antigens in formalin-fixed paraffin-embedded tissues in which avi-
din and biotin-labeled peroxidase are added sequentially to the system after primary 
antibody and biotin-labeled secondary antibody. The superiority of BRAB over LAB 
method is that there is no need to prepare protein-protein conjugate [20, 25].
Avidin extracted from egg white is a large tetrameric glycoprotein with 
molecular weight of about 66 KDa. Each subunit (MW 16,400 Da) contains one 
high-affinity binding site for biotin [26] and one oligosaccharide modification 
(Asn-linked). Tryptophan and lysine residues in each subunit are believed to be 
involved in forming the binding pocket with high affinity for biotin molecule 
[27–29]. Biotin with molecular weight of about 244.31 Da is a small molecule, 
which has only one binding site specific for avidin. Biotin can be easily conjugated 
with an antibody or other macromolecules such as fluorochrome and enzymes 
through other sites [6, 22].
Due to some limitations mentioned below, avidin has been mostly substituted 
by streptavidin in IHC applications. In this regard, labeled streptavidin-biotin 
methods (LSAB) are now more popular than LAB methods in both diagnostic 
and research IHC laboratories [30–34]. The sequence of streptavidin from 
Streptomyces avidinii shows only 30% similarity to avidin, while it has nearly 
identical secondary, tertiary, and quaternary structure [35]. It is a nonglycosyl-
ated protein with a molecular weight of 60 KDa [36]. Avidin is a basic glyco-
protein (pI ~ 10.5) that contains nearly 7% carbohydrates, which gives avidin a 
natural tendency to nonspecifically bind to lectin-like substances found in kid-
ney, liver, brain, and mast cells [7, 36–38]. Avidin can also bind electrostatically 
to negatively charged tissue elements at physiological pH. Sterptavidin (pI ~ 6.5), 
however, remains uncharged at neutral pH and does not contain carbohydrate 
in its structure eliminating its nonspecific binding to tissue lectins. In addition, 
streptavidin shows less propensity for aggregation [7, 39–41]. Although avidin 
shows higher binding affinity to free, unconjugated biotin, streptavidin has more 
tendency to bind biotin-protein conjugates [42]. Indeed, lot to lot variations in 
binding affinity of biotin and avidin have been reported, which negatively affect 
sensitivity and reproducibility of the procedure [7].
LAB/LSAB methods offer several advantages for IHC applications. Biological 
activities of macromolecules (e.g., enzymatic catalysis or antibody binding) are 
not affected when they are conjugated with biotin. On the other hand, the affinity 
of avidin/streptavidin to biotin is quite high enough that ensures the biotin-avidin/
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streptavidin complex is not disrupted by manipulations like multiple washing when 
the complex is immobilized in the tissue sections or by changes in pH and presence 
of chaotropes [22]. LAB/LSAB techniques considerably improve the sensitivity and 
efficiency of the immunohistochemical detections and allow researchers to use even 
more diluted primary antibodies. An immunohistochemical staining that employs 
a single layer of biotin-labeled monoclonal antibody provides sensitivity equivalent 
or much greater than PAP methods [43]. The increased sensitivity of avidin-biotin 
methods stems from larger numbers of biotin molecules that is conjugated to a 
primary antibody [20, 25, 44]. Due to very high sensitivity, IHC stainings using LAB/
LSAB techniques are rapid [45, 46]. LAB and LSAB technique can also be applied in 
an indirect manner, where biotinylated secondary antibodies are used in conjunction 
with unlabeled primary antibody [47].
The main challenge of LAB/LSAB techniques is the nonspecific (false-posi-
tive) staining, which occurs when the tissue of target contains endogenous biotin 
[6, 7]. Endogenous avidin biotin activity (EABA) or tissue affinity for avidin/
streptavidin is especially common in tissues and cells that contain high amount 
of biotin, such as placenta, mammary glands, kidney, adrenal cortex, brain, liver, 
fat, and mast cells [3, 6, 48]. EABA is much highlighted by heat-induced epitope 
retrieval (HIER) but also develops in tissues subjected to other types of antigen 
retrieval [49–51]. The level of endogenous biotin activity is especially higher in 
frozen compared to FFPE tissue sections, which leads to unwanted nonspecific 
reaction [52, 53]. EABA is typically found in cytoplasm, but it has been reported 
in the nucleus as well [51, 54–56]. Although paraffin embedding and formalin 
fixation have been found to significantly decrease the level of endogenous biotin, 
it is highly recommended to use a biotin blocking step when using avidin/strep-
tavidin-biotin-based detection systems to decrease endogenous biotin activity. 
Since the commercially available EABA blocking reagents (pure avidin and biotin 
solutions) are very expensive, many researchers prefer to use homemade block-
ing reagent containing egg white and 5% powdered milk as sources of avidin and 
biotin, respectively [57–60].
Figure 4. 
LAB/LSAB (a) and BRAB (b) immunostaining methods.
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5.2 Avidin-biotin complex (ABC) method
For signal amplification, another biotin-based IHC detection method was 
developed, namely avidin-biotin complex (ABC) method, in which a preformed 
avidin-biotin-peroxidase complex is used as the detection layer [20, 61]. This 
technique induces three different layers; an unconjugated primary antibody, a 
biotinylated secondary antibody, and finally a large complex of enzyme-labeled 
biotin and avidin, which is attached to the biotin molecules conjugated to the 
secondary antibodies (Figure 5). Two biotins from adjacent biotinylated enzyme 
molecules can be joined via an avidin molecule [62]. Four biotin binding site of 
avidin molecule could result in formation of lattice complexes in which avidins 
are attached together by biotinylated enzyme molecules creating a large complex, 
which is attached to the biotinylated secondary antibody [20, 63]. In normal 
circumstances, not all the four avidin’s capacity for biotin are taken up by biotinyl-
ated enzyme. This allows the complexes to attach to biotin of primary or secondary 
antibodies [64].
Before the advent of biotin-avidin-based methods, the PAP method was consid-
ered the most sensitive detection technique. The ABC method was then found to be 
nearly 40 times more sensitive compared to PAP method [65, 66].
By applying biotinylated primary antibodies, the ABC protocol can be shortened 
to a two-step method [3]. It is reported that application of biotin-labeled primary 
antibody in the two-step ABC method creates an equal sensitivity to the unconju-
gated antibody in the three-step ABC method. This finding proposes that biotinyl-
ation does not impair antibody activity and that application of a secondary antibody 
to intensify the reaction would not be necessary, if a suitable biotin-labeled primary 
antibody is used [43].
Although formation of lattice complexes of avidin and biotinylated enzyme seems 
to increase the sensitivity of ABC method compared to LAB/LSAB, it was found that 
Figure 5. 
Avidin/streptavidin immunostaining method.
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the sensitivity of ABC method is 5–10 times less than the LSAB method [67]. This 
disadvantage of ABC method is due to the large size of lattice complexes that hinder 
their penetration into the cells. Indeed, as with LAB/LSAB methods, the background 
in ABC method cannot be removed due to the irreversibility of the avidin-biotin 
reaction [21, 68]. As with LAB/LSAB methods, tissue endogenous biotin is one of the 
concerns in ABC-based IHC staining methods that results in nonspecific staining.
6. Polymer-based immunohistochemistry
Desire for IHC detection systems with improved sensitivity led to the develop-
ment of chain polymer-conjugate technology in the last decade of the former cen-
tury [69, 70]. Improved sensitivity of this technology is based on using synthetic or 
natural polymers that increase the capacity for incorporating ligands or enzymes to 
be coupled to linker antibodies [71–78]. Using this technology, much higher antigen 
detectability could be obtained in comparison to standard ABC and LSAB methods 
or in enzyme-antienzyme immune complex techniques (PAP and APAAP) [69, 70]. 
The chain polymer-conjugate technology normally utilizes a backbone of an inert 
polymer molecule of dextran [71–73], polypeptides [74], dendrimers [75, 77], or 
DNA branches [78]. The backbone is able to carry both antibodies and multiple 
enzymes. Hence, nearly 11 antibodies and up to 40 HRP molecules could be anchor 
to one 500 KDa dextran molecule [79].
In 1993, a one-step direct polymer immunohistochemical staining method, 
namely enhanced polymer one-step staining (EPOS) system, was introduced by 
Bisgaard and Pluzed [80]. In this method, up to 10 monoclonal primary antibodies 
and 70 enzyme molecules are attached to a dextran backbone with a high molecular 
weight. This would enable the whole immunohistochemical staining process (from 
primary antibody to enzyme) to be completed in a single step (Figure 6a) [81]. 
The whole process can be performed in nearly 7 min for frozen sections and to less 
than 3 h for regularly processed, paraffin-embedded specimens. Hence, when a 
quick and reproducible IHC-based diagnostic approach is demanded in emergency 
circumstances, for example, during surgeries, this method should be taken into 
consideration [82]. However, applicability of this method is restricted to primary 
antibodies provided by the manufacturer and was not suitable for user supplied 
primary antibodies.
To overcome this limitation, a polymer-enhanced two-step IHC detection 
system (EnVision, EV) was introduced in 1995. EV system contains secondary anti-
mouse and antirabbit Ig antibodies and could be applied to localize tissue-bound 
primary antibodies of mouse and rabbit origins (Figure 6b) [83–85]. The EnVision 
complex is composed of up to 20 secondary antibodies and nearly 100 molecules 
of peroxidase molecules, which all are directly attached to an activated dextran 
polymer backbone [86].
EnVision is a user-friendly technique and provides the users a rapid visual-
ization in only 45 min. This method offers a very high sensitivity and does not 
lead to false-positive reaction due to the endogenous biotin [87]. Although the 
EV system is a very expensive method, it can be applied with higher dilutions of 
primary antibodies. Indeed, because endogenous biotin is not a problem any-
more, EV permits more efficient heat-induced epitope retrieval (HIER) [69, 88]. 
The detection systems based on polymers could also be a choice for quick immu-
nostaining of frozen sections when tumor margin and micrometastasis is to be 
identified. Furthermore, polymer-based detection systems are sensitive enough 
to be applied as an alternative detection system in western blotting [89] and in 
chromogenic in situ hybridization (CISH) [90].
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Dextran carriers with a high molecular weight, however, appear to compromise 
the penetrative ability of the detection reagent due to spatial hindrance. Accordingly, 
the sensitivity of polymer-enhanced systems is profoundly affected by antigen 
localization. For instance, remarkably low sensitivity has been noticed in nuclear 
antigens [88, 91]. Indeed, in thick tissue sections, where the antigens are located 
beneath the surface area, only a part of antigens are amplified. This happens because 
of the large size of dextran-enzyme complex, which could not disperse into the 
deeper layers making quantitative results unreliable [87]. Subsequently, EnVision+ 
was developed, which was a modified version of EV system with higher sensitivity. 
EnVision+ contains a mixture of dextran polymers with two different secondary 
antibodies (goat antirabbit and goat antimouse IgG) anchored to it [86, 88, 92]. 
Nonetheless, EnVision systems were reported to give less sensitivity in case of some 
antibodies especially those that require proteolytic digestion, which was believed to 
stem from problems of tissue penetration of the labeled polymer.
Although the application of polymer gives a chance of increasing the number 
of enzymes coupled to the carrier backbone, it also profoundly increases the size 
of complex. Therefore, enzyme density per unit surface may not be increased 
to the degree that would be expected. Hence, it would be a desirable approach 
to design a compact polymer-enzyme-linker antibody conjugates with optimal 
number of enzyme molecules. Based on this goal, Shi et al. [91] suggested to 
use small linear molecules that have a capacity to polymerize with enzymes 
and linker antibodies in a tightly packed size. The IHC results with this newly 
designed detection system (Power Vision) showed that it possesses compact size 
and, compared to conjugates containing polymer linkers, shows higher detection 
efficiency for antigens located on the cell surface or in the nucleus [91]. Compared 
to EnVision+, this “second-generation” polymer-based conjugate was found to 
Figure 6. 
Polymer-based immunostaining method: (a) EPOS and (b) EnVision.
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be less expensive and fast and showed better reproducibility and capacity to be 
standardized [93, 94]. From clinical point of view, these methods are extremely 
useful when emergency results (for example, assessing the intraoperatively surgi-
cal margins of tumor specimens) are needed [95].
7. Tyramide-based signal amplification
7.1 Biotinylated tyramide signal amplification
In 1989, a novel signal amplification method for immunoassays was introduced 
by Bobrow et al. called catalyzed reporter deposition (CARD). The CARD was first 
used in western blots and immunodots [96–98] and was then adapted for IHC by 
Adams [99].
The signal amplification in this system is based on an analyte-dependent reporter 
enzyme (ADRE), which catalyzes the deposition of additional reporter molecules. The 
first step of this system relies on the same principle as LAB/LSAB detection system. 
Accordingly, primary antibody is first added to the tissue section followed by biotinyl-
ated secondary antibody and either HRP-labeled streptavidin (in tyramine signal 
amplification (TSA)) or streptavidin-biotin-HRP complex (in catalyzed signal ampli-
fication (CSA)). The amplification process happens when the peroxidase enzyme 
(ADRE) oxidizes the phenolic components to produce extremely unstable and reactive 
intermediate radicals, which are then bound to a tissue section [96, 100]. Tyramine, 
a biogen amine derived from aromatic amino acid tyrosine, is a substrate commonly 
used in this technique. It contains an amine at one end and a phenol at another end, 
which is used by peroxidase enzyme. The amine group is employed to conjugate the 
molecule with biotin or any other target molecules via an amide bound [101]. In the 
presence of HRP and H2O2, biotinylated tyramine is oxidized and resulting highly 
reactive radicals will react with electron-rich aromatic components, such as tyrosine-
rich moieties of proteins in the vicinity of the HRP binding sites in tissues. This 
binding occurs very rapidly within 10 min. Due to a very short half-life of tyramide 
radicals, they are deposited at the same location where they are generated [102]. This 
reaction is then followed by incubation of the tissues with streptavidin-peroxidase 
complex. This complex is attached to the biotin sites of the tyramine, which are 
remained free. This reaction is restricted to the sites of primary antibody binding site 
where HRP had previously accumulated (Figure 7).
Because of the high sensitivity of this method, biotinylated tyramide amplifica-
tion enabled many antigens to be traced, which had previously been unreactive 
in formalin-fixed paraffin-embedded tissues [101]. In comparison to the avidin-
biotin-based methods, biotinylated tyramide signal amplification exhibits 5- to 
10-fold more sensitivity. Some researchers believed in even more sensitivity [103]. It 
was reported by Sanno et al. that staining of pituitary hormones with CSA showed 
nearly 100-fold higher sensitivity compared to standard ABC method [104]. It 
is recommended to use this method when (1) antigen expression in target tissue 
is extremely low or the amount of antibody available is limited and (2) primary 
antibodies possess low affinity or are not compatible with paraffin-embedded tissue 
sections [104, 105]. Repeating the biotinyl-tyramide reaction can further increase 
the signal intensity. However, this circuit is restricted to only two or three rounds 
before the background noise becomes an issue [106]. CSA and/or TSA methods are 
found to be cheaper than EnVision system but with the same effectiveness [86].
These methods, however, are laborious because they involve an initial avidin-
biotin procedure followed by the tyramine reaction. Background can also be 
considered a serious problem, particularly with HIER. In this case, more prolonged 
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treatment of tissues to quench endogenous peroxidase or endogenous avidin-biotin 
activities (EABA) is usually necessary [105, 107–109]. Although TSA/CSA detection 
methods have resulted in satisfactory results in terms of significantly increased 
sensitivity in IHC and in situ hybridization (ISH), they are not widely employed in 
diagnostic pathology. The reasons include: additional steps that make the method 
more time-consuming, nonspecific background staining, and that optimal AR 
treatment with existing methods may achieve equivalent results and that second-
generation polymer-based methods are simpler and equally sensitive [14, 110, 111].
7.2 Biotin-free TSA/CSA
In an attempt to reduce the problems associated with endogenous biotin in con-
ventional tyramide signal amplification, a biotin-free system, fluorescyl-tyramide 
amplification system (FT-CSA or CSAII), was introduced. Rather than biotinyl-
tyramide, this system uses fluorescyl-tyramide and does not contain avidin/biotin 
reagents avoiding the problem associated with endogenous biotin. In this method, 
addition of primary antibody is followed by a peroxidase-labeled secondary anti-
body. Peroxidase enzyme is responsible to catalyze the transformation and deposi-
tion of fluorescyl-tyramide in the tissue section. When the reaction terminates, it 
could be inspected by fluorescence microscopy. The produced signals could even be 
converted to a colorimetric reaction by using peroxidase-conjugated antifluorescein 
antibody and a diaminobenzidine-hydrogen peroxide substrate.
This method is highly sensitive enabling researchers to detect and localize anti-
gens with low expression level and to use primary antibodies with very low affinities 
[105, 106]. Alternative reporter includes dinitrophenol, which also results in marked 
reduction of background from endogenous biotin. Absence of nonspecific staining 
is due to no endogenous tissue distribution of dinitrophenol [14].
In the latest improvement of the biotin-free CSA method, fluorescein is con-
served in the substrate, while the tyramine is substituted with ferulic acid, which 
is a much better peroxidase substrate and increases signal-to-noise ratio. In this 
system, the incubation time in each step can be significantly reduced, making it 
possible to stain a tissue in less than 1 h [112].
Figure 7. 
Tyramide-based immunostaining method.
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8. Rolling circle amplification
Rolling circle amplification (RCA) reaction was first developed for the purpose 
of nucleic acid detection [106], but it was then adapted for amplification of signals 
from antibodies bound to antigens [113–118]. RCA is an enzymatic process in which 
a short DNA or RNA primer is amplified using a circular DNA template and special 
DNA or RNA polymerases to form a long single-stranded DNA or RNA [119, 120]. 
The end product of RCA is a long continuous sequence of DNA containing several 
tandem repeats complementary to the circular template. Unlike PCR, RCA could be 
performed at a constant temperature (room temperature to 37°C). A RCA reaction 
contains five different components: (i) a short DNA or RNA primer, (ii) a poly-
merase enzyme (e.g., Phi29 DNA polymerase for DNA, and T7 RNA polymerase for 
RNA), (iii) a suitable buffer compatible with polymerase enzyme, (iv) a circular 
DNA template, and (v) deoxy nucleotide triphosphates (dNTPs) [121].
RCA reaction has three different steps: (1) the circular DNA template with 
typically ~15–200 nt in length is synthesized through the intramolecular ligation of 
phosphate and hydroxyl end groups of a linear probe with the use of the target DNA 
or RNA as a ligation template [121–123], (2) the polymerase enzyme continuously 
adds dNTPs to a circular template-annealed primer to form a long ssDNA with tens 
to hundreds of tandem repeats, and (3) the RCA end products could be detected 
and even monitored by different signal readout methods (Figure 8) [121]. Different 
methods are available to visualize and also analyze the RCA process including  
(a) labeling the RCA products directly during the amplification process by using 
Figure 8. 
Rolling circle amplification immunostaining method. (1) Immunoconjugate bound to target antigen. (2) RCA 
primer hybridized to circle template (3) Synthesis of new DNA strand by DNA polymerase (4) Detection of 
amplified DNA by enzyme-labeled probe at the site of bound antibody.
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fluorescent dyes-conjugated dNTPs; (b) detecting the RCA product with hybrid-
ization of fluorophore-tethered complementary strands; quantum dots or gold 
nanoparticles can be attached to RCA products via a complimentary strand to 
visualize RCA product; (c) using molecular beacon for fluorescent detection of 
RCA products; (d) using DNA binding dyes such as SYBR green; (e) using biotinyl-
ated decorator and streptavidin-HRP conjugate or by DNA-peptide nucleic acid 
(PNA) intercalating dye for colorimetric detection of RCA product; and (f) using 
luciferase to generate light for bioluminescence detection of RCA products [121].
One of the important advantages of RCA is that circular templates can be custom-
ized so that the signals of a single binding event are amplified in an exponential man-
ner (e.g., multiprimed RCA) [124–126]. In this approach, signal amplification more 
than 109-fold is feasible, while a linear mode of RCA has a capacity to amplify signals 
to nearly 105-fold [127]. RCA reactions could be accomplished on a solid surface and 
also in a solution environment. In solid-phase RCA, reaction is conducted on a solid 
surface such as glass, microwell plates, microbead or nanobead particles, paper strips, 
or microfluidic devices. This system gives researchers an advantage of high-throughput 
analysis and potential for easy detection of target from complex sample matrices [121].
RCA is appeared to be a powerful method in immunoassays. The combination of 
RCA method with ELISA is found to grant more sensitivity and decrease the lower 
detection limit. In this regard, there is an approach called immuno-RCA in which, 
a RCA primer-conjugated antibody is applied on a target antigen that has been 
coated on a solid surface followed by a RCA reaction. The first immuno-RCA test 
was introduced by Schweitzer B et al. (2000) on a glass slide for IgE quantification 
[128]. From that time, solid-phase RCA has become popular as signal amplifica-
tion method in antibody microarray analysis of multiplexed proteins [129–132]. A 
sandwich immuno-RCA has been adapted to detect the target with high sensitivity. 
In this technique, the target antigen in biological media is first captured on a solid 
surface using coated antibody. In the next step, a RCA primer-conjugated secondary 
antibody is applied to conduct the RCA reaction [133–135].
Konry et al. [136], by combining the capacity of RCA reaction to detect a single-
molecule and microfluidic technology, demonstrated the feasibility of identification 
of specific protein markers on tumor cell surfaces in miniaturized nanoliter reaction 
droplets. This approach of signal amplification in a microfluidic format could improve 
the applicability of existing methods by reducing consumption of sample and reagent 
and increasing the specificity and sensitivity for various applications such as early 
diagnosis of cancer [136]. Specific immunocytochemical and immunohistochemial 
identification of a wide range of intracellular molecules (prostate-specific antigen and 
vimentin) and cell surface antigens (epithelial membrane antigen, CD3 and CD20) 
in a variety of tissues (tonsil and breast) and cell lines (U266, Jurkat) has successfully 
been accomplished using RCA-mediated signal amplification. Indeed, immuno-RCA 
was reported to give more uniform staining pattern compared to the conventional 
methods [129]. In situ proximity ligation assays (in situ PLA) are an important adapta-
tion of the RCA method in which primary antibodies against two distinct antigens 
are applied. Having two antigens in close proximity to each other, RCA reaction will 
occur and the proximity of two distinct antigens can be visualized [137].
It has been shown that attachment of a RCA primer to primary or secondary anti-
body does not impair affinity or avidity of the conjugate. Nonetheless, RCA reaction 
adds 60–90 min to the conventional IHC protocol. Although RCA is able to generate 
amplification of DNA up to 109-fold, immuno-RCA in LSAB-based IHC applications 
is able to increase the signal to only about fourfold [129]. Simultaneous evaluation 
of TSA and RCA detection techniques by Warford et al. revealed that both methods 
are capable to produce results with a high signal-to-noise ratio. However, they found 
TSA detection system to be more sensitive than the RCA method [14].
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9. Choice of detection system and concluding remarks
The sensitivity of an IHC staining is a function of detection method for signal 
amplification [138].
The choice of a detection system is mainly determined by laboratories based on 
the nature of the specimen, expression level of the antigen, cost, desired sensitivity, 
and possible automation [53]. Choosing an appropriate detection system enables 
maximum sensitivity and optimum visibility of the immune reaction with the 
fewest steps and in the shortest time [139]. As a general rule, the more complex an 
IHC method, the more sensitive it is. One- or two-step IHC procedures are usually 
less sensitive than more complex, multistep procedures. In addition, the detection 
system must be accurate, reproducible, and results in a high signal-to-noise ratio 
[140]. When choosing a desirable detection system, several factors are needed to be 
taken into consideration: (1) the expertise/experience of the technician; (2) type of 
the antigen to be identified; for example, some antigens are widely expressed and 
do not need a sensitive method to be visualized; (3) number of tests and the amount 
of antibody that is available; (4) the affinity of the antibody: each antibody has its 
own affinity that requires a specific detection system, antibodies with less affinity 
usually need more sensitive detection systems; (5) species idiosyncrasies (does 
the tissue contain endogenous biotin), (6) budget; (7) localization of the antigen 
of interest (some detection systems do not have high cell penetration capacity due 
to the large size and regardless of having high sensitivity for detection of surface 
antigens, do not yield a high sensitivity for intracellular or nuclear antigens),  
(8) the need for or type of antigen retrieval; typically, a non-biotin-labeled detec-
tion system is recommended if HIER is used to avoid background from endogenous 
avidin-biotin activity (EABA) [141].
A detection system should be compatible with animal species as well. A detection 
system with an outstanding performance in human is not always suitable for animal 
models [6, 142]. The sensitivity of commercially available detection kits, some 
optimized for particular animal species, should be validated in-house before use. 
The secondary and tertiary reagents of some kits may contain antibodies or other 
compounds that potentially nonspecifically react with tissue antigens, leading to a 
background or staining. This is one justification for negative controls in IHC [141].
As a further general rule, one should always try to use the simplest detection 
method with sensitivity enough for detection of the antigen. The multilayering of 
detection antibodies beyond this threshold can be problematic as with the addition 
of every new step, the risk of nonspecific interaction with the preparation increases. 
There are some exceptions to this rule. For example, in tumor-specific antigens, 
which are not expressed in normal condition, the use of more sensitive methods 
might decrease detection level cutoff and increase the likelihood for early detection 
of cancer [143, 144].
In emergency conditions when results are needed in a short amount of time 
(such as evaluating intraoperatively surgical margins of tumor specimens), apply-
ing a detection method with high sensitivity will definitely improve accuracy of the 
procedure and help surgeon to obtain wider surgical margins if needed.
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